Top news of the week: 11.08.2020.
Pharmacology, Medicine, Classification of Pharmaco-Therapeutic Referrals, Mitochondrial DNA, Form 10-K, French people
Healthcare
Bausch Health, Fennec Pharma FDA Decisions And Smid-cap Earnings #BioTech #health via https://t.co/2sI0UxJbpn https://t.co/j4DPTG90bI
OpenThe Week Ahead In Biotech: Bausch Health, Fennec Pharma FDA Decisions And Smid-cap Earnings
Biotech stocks advanced in the week ended Aug. 7, buoyed by multiple catalysts. Aside from the broader market strength, mostly positive earnings and continuing coronavirus...
Restoring Cellular Power Outages: A New Drug to Treat Mitochondrial Diseases https://t.co/OqTqbU4hgZ https://t.co/uIVP3CdMyK
OpenRestoring Cellular Power Outages: A New Drug to Treat Mitochondrial Diseases
A small biotech company is aiming to recharge tired cells, giving mitochondrial disease patients new hope of a disease-specific treatment.
Can't be pressured to launch coronavirus vaccine, says Bharat Biotech CMD #BioTech via https://t.co/2sI0UxJbpn https://t.co/JNJspapqdK
OpenCOVID-19 vaccine: Can't be pressured to launch coronavirus vaccine, says Bharat Biotech CMD
Coronavirus vaccine update: The pandemic is putting pressure on the company to come out with a vaccine quickly, but we cannot rush as safety and quality are paramount, says Krishna M Ella
GentiBio Launches with $20 Million Seed Funding from Novartis and Others https://t.co/6WueJfK5Dq https://t.co/Kfa89GuKbE
OpenGentiBio Launches with $20 Million Seed Funding from Novartis and Others
GentiBio focuses on engineered regulatory T-cells (EngTregs) to treat autoimmune, alloimmune, autoinflammatory and allergic diseases.
Meet Mesoblast’s talented Board of Directors: (L-R) Vice Chairman William Burns; non-executive Directors Donal O’Dwyer, Michael Spooner and Shawn Cline Tomasello; Executive Director Silviu Itescu; non-executive Director Eric Rose; Chairman Joseph Swedish. https://t.co/IjIU3CHEko https://t.co/vSrabAApAE
OpenBoard of Directors
Learn more about Mesoblast's adult stem cell research and the potential to cure human disease.
Hospital president wrote opinion piece critical of drug pricing efforts, but didn’t disclose role on Moderna board
Dr. Elizabeth Nabel criticized efforts to control drug prices in an opinion piece earlier this year, but didn't disclose her role as a Moderna board member.
Pfizer Announces Agreement with Gilead to Manufacture Remdesivir for Treatment of COVID-19 #BioTech via https://t.co/2sI0UxJbpn https://t.co/3NaaqZIcxr
OpenPfizer Announces Agreement with Gilead to Manufacture Remdesivir for Treatment of COVID-19
Pfizer Inc. (NYSE: PFE) today announced a multi-year agreement with Gilead Sciences, Inc. to manufacture and supply Gilead’s investigational antiviral remdesivir, as one of multiple ...
Evotec and Secarna Pharmaceuticals form strategic partnership in the field of antisense therapy
https://t.co/rUmdEdlIcE
OpenEvotec and Secarna Pharmaceuticals form strategic partnership in the field of antisense therapy
Evotec is a globally leading drug discovery alliance and development partnership company headquartered in Hamburg, Germany.